IP Library Granted Patent US 7,842,291
Granted Patent B1
US 7,842,291 · App. 11/802,321 · Granted Nov 30, 2010

Methods and compositions for diagnosing and treating diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,291
App. No.
11/802,321
Granted
Nov 30, 2010
Kind
B1
Abstract

Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Claims (4)

1. A method of inhibiting proliferation of pancreatic cancer cells, the method comprising contacting the pancreatic cancer cells with an isolated antibody that selectively binds to a SLC5A6 protein to thereby inhibit proliferation of the pancreatic cancer cells, wherein the amino acid sequence of the SLC5A6 protein comprises a sequence selected from the group consisting of SEQ ID NOS:7-9.

2. The method of claim 1 , wherein the antibody is coupled to at least one agent selected from the group consisting of drugs, toxins, differentiation inducers, and radionuclides.

3. The method of claim 1 , wherein the contacting step comprises administering a therapeutically effective amount of the isolated antibody to an individual harboring the pancreatic cancer cells.

4. The method of claim 2 , wherein the contacting step comprises administering a therapeutically effective amount of the isolated antibody to an individual harboring the pancreatic cancer cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2007
From: VAN ORDEN, KAREN; HE, TAO; LEE, CANDY; RUBEN, STEVE; MOORE, PAUL A.; BIRSE, CHARLES E.; MESRI, MEHDI; JOSELOFF, ELIZABETH G.
To: APPLERA CORPORATION
Reel/Frame 019684/0770 →